Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$537K Sell
4,176
-27
-0.6% -$3.16K 0.22% 93
2026
Q1
$506K Sell
4,203
-592
-12% -$68.3K 0.26% 83
2025
Q4
$505K Sell
4,795
-3,263
-40% -$306K 0.26% 85
2025
Q3
$676K Sell
8,058
-828
-9% -$68.2K 0.25% 78
2025
Q2
$701K Sell
8,886
-702
-7% -$55.8K 0.37% 58
2025
Q1
$861K Buy
9,588
+4,890
+104% +$457K 0.35% 64
2024
Q4
$464K Buy
+4,698
New +$484K 0.21% 99

Other funds holding MRK

AmeriFlex Group's MRK Position: Q2 2026 in Review

AmeriFlex Group reduced its Merck (MRK) stake by 0.64% in Q2 2026, selling an estimated $3.16K and leaving 4,176 shares worth $537K. The position accounts for 0.22% of the portfolio, ranked #93.

AmeriFlex Group first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $861K in Q1 2025. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • AmeriFlex Group held 4,176 shares of Merck worth $537K as of Q2 2026.
  • AmeriFlex Group sold 27 Merck shares in Q2 2026, an estimated $3.16K.
  • Merck made up 0.22% of AmeriFlex Group's portfolio in Q2 2026, its #93 holding.
  • AmeriFlex Group first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • AmeriFlex Group's Merck position peaked at $861K in Q1 2025.
  • 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.